Stock List

Search by Ticker



Edwards Lifesciences Corporatio (NYSE:EW)
Stock Analysis

▲ 1.43%1.15

Stock Analysis

The following stock analysis is based on 9.5 years of data (i.e. since Sep 20, 2013). All the stock history has been downloaded.

Stock Exchange

Edwards Lifesciences Corporatio trades on the NYSE exchange in USD dollars.


It is in the healthcare sector.

Current Status of Edwards Lifesciences Corporatio

It is currently trading at $81.64 ($80.49 the previous day).


The next reporting date is in 26 days (2023 04 25).

CNN estimates profits for the upcoming quarter will be $0.61 per share ($1.4B). The current Canada / US exchange rate is 1.35644.

Over the past 12 months, $0 worth of shares have been purchased and $43579444 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 11.7% per year assuming steady exponential growth. The actual 5 year average is 20.98. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year91.757240358744-16.8- Below Average
2 year110.2811400684938+ Above Average
3 year79.9002161812313.3- Below Average
4 year70.53836065573837.3+ Above Average
5 year51.38098859315633.1+ Above Average
Edwards Lifesciences Corporatio is projected by analysts to get to $86.50 within the next 12 months (6%), but preticted targets range from as high as $100.00 (22.5%) and as low as $67(-17.9%).


The worst drop it has had in recent years is -48.0%. It has a steady shape to the stock curve, which means the stock continues on a consistent trend except during extreme periods of volitility, but usually recovers quickly. These stocks are very safe and do not have to be checked often.

Stock shape test


With an average increase of 11.7% year over year, if Edwards Lifesciences Corporatio is bought at the worst time, Stockmarketizer analysts estimate it will take 49.2 months before the stock will recover to the original purchase price. The P/E value is 32.92. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.


Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter. Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.

The company was founded in 1958 and has since grown to 12,200 employees and $3.4 billion in revenue by 2017. Their headquarters is located in Irvine, California (USA). The chairman and CEO is Michael A. Mussallem. The company is part of the S&P500.

Tradingview BuySell Widget

Yahoo News Feed

Here's Why You Should Retain Avantor (AVTR) Stock for Now

Tue, 28 Mar 2023 15:40:03 Investors continue to be optimistic about Avantor's (AVTR) strong product portfolio.... Read Full Article

NextGen's (NXGN) New Cloud-Based Solution to Improve Workflow

Tue, 28 Mar 2023 15:21:03 NextGen's (NXGN) latest product is expected to simplify connectivity for healthcare providers, thereby solving clinical data exchange challenges.... Read Full Article

Edwards Lifesciences' (NYSE:EW) investors will be pleased with their respectable 79% return over the last five years

Mon, 27 Mar 2023 10:47:15 Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...... Read Full Article

HOLX vs. EW: Which Stock Is the Better Value Option?

Thu, 23 Mar 2023 15:40:03 HOLX vs. EW: Which Stock Is the Better Value Option?... Read Full Article

5 big analyst cuts: Tesla stock slumps on Berenberg downgrade | Pro Recap

Thu, 09 Mar 2023 07:07:57 Tesla (NASDAQ:TSLA) shares fell 3% yesterday after Berenberg downgraded the company to Hold from Buy with a price target of $210.00 (from $200.00) as it believes the upside is limited following the year-to-date outperformance. Long-term, Berenberg remains bullish on the company and ...... Read Full Article

HOLX or EW: Which Is the Better Value Stock Right Now?

Tue, 07 Mar 2023 16:40:04 HOLX vs. EW: Which Stock Is the Better Value Option?... Read Full Article

Abbott (ABT) Makes Progress in the TAVI Space With Navitor

Tue, 07 Mar 2023 14:45:02 Results from Abbott's (ABT) PORTICO study support Navitor's recent FDA approval to treat patients with severe aortic stenosis who are at high or extreme risk for open-heart surgery.... Read Full Article

Abbott's (ABT) MitraClip Device Shows Favorable Outcome

Tue, 07 Mar 2023 13:03:01 Abbott's (ABT) landmark COAPT trial demonstrated that MitraClip is safe and effective and can reduce the hospitalization rate.... Read Full Article


Mon, 06 Mar 2023 14:00:00 Edwards Lifesciences (NYSE: EW) today highlighted new important data examining mortality rates and cardiac damage of early-stage aortic stenosis (AS) sufferers, along with data examining 10-year transcatheter aortic valve replacement (TAVR) re-intervention rates using real-world Medicare data. Together these studies, ...... Read Full Article

Why Is Edwards Lifesciences (EW) Down 2% Since Last Earnings Report?

Thu, 02 Mar 2023 16:30:04 Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.... Read Full Article

Humana (HUM) Exits Business Line to Focus More on Core Units

Mon, 27 Feb 2023 13:55:01 Humana (HUM) will depart from the Employer Group Commercial Medical Products business so that it can invest more funds to grow its core Insurance business lines.... Read Full Article

Zacks Industry Outlook Highlights Edwards Lifesciences, IDEXX Laboratories and Hologic

Fri, 24 Feb 2023 08:13:08 Edwards Lifesciences, IDEXX Laboratories and Hologic have been highlighted in this Industry Outlook article.... Read Full Article

3 Medical Instruments Stocks to Buy Amid Improving Industry Trends

Thu, 23 Feb 2023 15:27:03 The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most. Yet, the ongoing inflation, in the form of rising freight, raw material costs, is disrupting the ...... Read Full Article

Edwards Lifesciences (EW) Gains on Innovation, Margin Growth

Mon, 20 Feb 2023 15:21:03 In Edwards Lifesciences' (EW) Smart Recovery portfolio, the adoption of FloTrac and ClearSight sensors remains strong.... Read Full Article

With 87% ownership, Edwards Lifesciences Corporation (NYSE:EW) boasts of strong institutional backing

Sun, 19 Feb 2023 12:20:17 Every investor in Edwards Lifesciences Corporation ( NYSE:EW ) should be aware of the most powerful shareholder groups...... Read Full Article

Interview With David Rolfe of Wedgewood Partners

Fri, 17 Feb 2023 20:48:00 David Rolfe is the chief investment officer and portfolio manager at Wedgewood Partners. Under his leadership, Wedgewood was named a separately managed account (SMA) manager of the year in both 2011 and 2013. John Rotonti: Tell us about Wedgewood Partners.... Read Full Article

SONVY or EW: Which Is the Better Value Stock Right Now?

Thu, 16 Feb 2023 16:40:04 SONVY vs. EW: Which Stock Is the Better Value Option?... Read Full Article

Select Medical (SEM) Enters JV to Boost New Jersey Healthcare

Wed, 15 Feb 2023 17:22:05 Select Medical (SEM) collaborates with AtlantiCare to open an inpatient rehabilitation hospital and jointly manage the operations of SEM's outpatient centers across New Jersey.... Read Full Article

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Mon, 13 Feb 2023 14:00:02 Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.... Read Full Article

Is Applied Molecular Transport (AMTI) Stock Outpacing Its Medical Peers This Year?

Wed, 08 Feb 2023 14:40:02 Here is how Applied Molecular Transport Inc. (AMTI) and Edwards Lifesciences (EW) have performed compared to their sector so far this year.... Read Full Article